Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report)’s share price fell 0.7% during trading on Wednesday . The stock traded as low as $14.40 and last traded at $14.40. 1,294 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 12,097 shares. The stock had previously closed at $14.50.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group lowered shares of Kyowa Kirin to a “hold” rating in a report on Tuesday, September 8th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce”.
Check Out Our Latest Stock Analysis on KYKOF
Kyowa Kirin Trading Down 0.7%
Kyowa Kirin Company Profile
Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.
The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.
Recommended Stories
- Five stocks we like better than Kyowa Kirin
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
